Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Brain spectrin, a membrane-associated protein related in structure and function to erythrocyte spectrin.

Bennett V, Davis J, Fowler WE.

Nature. 1982 Sep 9;299(5879):126-31.

PMID:
7110333
2.
4.

Autolysis of calcium-activated neutral protease of chicken skeletal muscle.

Suzuki K, Tsuji S, Ishiura S, Kimura Y, Kubota S, Imahori K.

J Biochem. 1981 Dec;90(6):1787-93.

5.

Activation by hemoglobin of the Ca2+-requiring neutral proteinase of human erythrocytes: structural requirements.

Pontremoli S, Sparatore B, Melloni E, Michetti M, Horecker BL.

Biochem Biophys Res Commun. 1984 Aug 30;123(1):331-7.

PMID:
6089797
6.

Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Fairbanks G, Steck TL, Wallach DF.

Biochemistry. 1971 Jun 22;10(13):2606-17. No abstract available.

PMID:
4326772
7.

Altered calcium uptake in cultured skin fibroblasts from patients with Alzheimer's disease.

Peterson C, Gibson GE, Blass JP.

N Engl J Med. 1985 Apr 18;312(16):1063-5. No abstract available.

PMID:
3982463
8.

Diminished mitogen-induced calcium uptake by lymphocytes from Alzheimer patients.

Gibson GE, Nielsen P, Sherman KA, Blass JP.

Biol Psychiatry. 1987 Sep;22(9):1079-86.

PMID:
3651529
9.

Neurofilaments: structure, metabolism and implications in disease.

Schlaepfer WW.

J Neuropathol Exp Neurol. 1987 Mar;46(2):117-29. Review. No abstract available.

PMID:
3546600
10.

Calcium-activated neutral protease and its endogenous inhibitor. Activation at the cell membrane and biological function.

Suzuki K, Imajoh S, Emori Y, Kawasaki H, Minami Y, Ohno S.

FEBS Lett. 1987 Aug 17;220(2):271-7. Review.

12.

Hydrolytic and autolytic behavior of two forms of calcium-activated neutral protease (CANP).

Inomata M, Hayashi M, Nakamura M, Imahori K, Kawashima S.

J Biochem. 1985 Aug;98(2):407-16.

13.

Binding to erythrocyte membrane is the physiological mechanism for activation of Ca2+-dependent neutral proteinase.

Pontremoli S, Melloni E, Sparatore B, Salamino F, Michetti M, Sacco O, Horecker BL.

Biochem Biophys Res Commun. 1985 Apr 16;128(1):331-8.

PMID:
2985077
14.

Kinetic properties of the [Ca2+ + Mg2+]-ATPase in Alzheimer and normal fibroblasts at low free calcium.

Rizopoulos E, Chambers JP, Martinez AO, Wayner MJ.

Brain Res Bull. 1988 Nov;21(5):825-8.

PMID:
2975526
15.

Neuropathological classification of Huntington's disease.

Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr.

J Neuropathol Exp Neurol. 1985 Nov;44(6):559-77.

PMID:
2932539
16.

Synaptic loss in Alzheimer's disease and other dementias.

Hamos JE, DeGennaro LJ, Drachman DA.

Neurology. 1989 Mar;39(3):355-61.

PMID:
2927643
17.

Glutamate neurotoxicity and diseases of the nervous system.

Choi DW.

Neuron. 1988 Oct;1(8):623-34. Review. No abstract available.

PMID:
2908446
18.

Diagnosis of Alzheimer's disease.

Khachaturian ZS.

Arch Neurol. 1985 Nov;42(11):1097-105. No abstract available.

PMID:
2864910
19.

The ultrastructural localization of calcium-activated protease "calpain" in rat brain.

Perlmutter LS, Siman R, Gall C, Seubert P, Baudry M, Lynch G.

Synapse. 1988;2(1):79-88.

PMID:
2843999
20.

Effects of a monoclonal anti-calpain antibody on responses of stimulated human neutrophils. Evidence for a role for proteolytically modified protein kinase C.

Pontremoli S, Melloni E, Damiani G, Salamino F, Sparatore B, Michetti M, Horecker BL.

J Biol Chem. 1988 Feb 5;263(4):1915-9.

Supplemental Content

Support Center